Macroheterocylic compounds useful as kinase inhibitors
US6828327B2 · kind B2 · utility
6Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2001 |
| Grant date | Dec 7, 2004 |
| Priority date | — |
| Expiry date | Dec 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D515/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to macroheterocyclic compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.